Eric J Chow MD
Associate Professor, Pediatrics, University of Washington School of Medicine
Join to view full profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-520-5000
Fax+1 206-987-3946
Dr. Chow is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Pediatric Hematology/Oncology, 2004 - 2007- University of WashingtonResidency, Pediatrics, 2001 - 2004
University of California San Francisco School of MedicineClass of 2001
University of California, Berkeley, School of Public HealthMPH, Epidemiology & Biostatistics
Certifications & Licensure
ID State Medical License 2022 - 2027
MT State Medical License 2009 - 2027
WA State Medical License 2004 - 2027
AK State Medical License 2021 - 2026
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors
- Communicating Health Information and Improving Coordination With Primary Care Start of enrollment: 2017 Mar 01
- SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart Start of enrollment: 2018 Aug 31
Publications & Presentations
PubMed
- Longitudinal Ovarian Reserve in Female Adolescents/Young Adults With Lymphoma: A Report From Children's Oncology Group Study ALTE11C1.Lindsay F Schwartz, Clarisa R Gracia, Venkatraman E Seshan, Jill P Ginsberg, Richard Aplenc
Pediatric Blood & Cancer. 2026-11-01 - Immunotherapy-Based Therapies in Pediatric Hodgkin Lymphoma: Potential to Narrow the Gap in Long-Term Survival.Jenna R Rogers, Zachary J Ward, Angela M Feraco, Sharon M Castellino, Kayla L Stratton
Journal of the National Cancer Institute. 2026-10-01 - Accelerated Aging and Risk of Subsequent Neoplasms in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study.Amy M Berkman, Shalini Bhatia, Sedigheh Mirzaei, Kendrick Li, Cindy Im
Cancer Epidemiology, Biomarkers & Prevention. 2026-10-01
Abstracts/Posters
- Health Care Costs Associated with Contemporary Chronic Myelogenous Leukemia (CML) Therapy Compared to Other Hematologic Malignancies (HEM)Eric J Chow, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Chronic Health Conditions and Late Mortality Among Survivors of Childhood Acute Myeloid Leukemia: A Report from the Childhood Cancer Survivor Study (CCSS)Clinically Re...Eric J Chow, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Protective Drug Dexrazoxane Reduces Heart Damage in Pediatric Cancer Survivors Years After Treatment EndsAugust 7th, 2026- Dexrazoxane Protects the Heart Long Term for Kids Being Treated for CancerMarch 16th, 2023
- Survivors of Childhood Cancer More Likely to Be Undertreated for CVDJune 15th, 2022
Grant Support
- SALSA - Study of Active Lifestyle ActivationFRED HUTCHINSON CANCER CENTER2021–2026
- SALSA - Study of Active Lifestyle ActivationFRED HUTCHINSON CANCER CENTER2021–2026
- Machine Learning-Based Identification of Cardiomyopathy Risk in Childhood Cancer SurvivorsFRED HUTCHINSON CANCER CENTER2023–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: